Polar Asset Management Partners’s TriSalus Life Sciences TLSI Stock Holding History

Polar Asset Management Partners’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-55,707	Closed	-$553K	–	1314
2022 Q3	$553K	Hold	55,707	–	–	0.01%	809
2022 Q2	$548K	Buy	+55,707	New	+$547K	0.01%	796
2021 Q4	–	Sell	-392,808	Closed	-$3.9M	–	1509
2021 Q3	$3.9M	Sell	392,808 -282,192	-42%	-$2.76M	0.04%	463
2021 Q2	$6.55M	Hold	675,000	–	–	0.07%	319
2021 Q1	$6.52M	Buy	+675,000	New	+$6.85M	0.06%	280

Other funds holding TLSI

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

DFCM

Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Polar Asset Management Partners's TLSI Position: Q4 2022 in Review

Polar Asset Management Partners sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 55,707 shares — an estimated $553K sold.

Polar Asset Management Partners first reported a position in TLSI in Q1 2021 and held it in 5 quarters. The position peaked at $6.55M in Q2 2021. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

Polar Asset Management Partners reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
Polar Asset Management Partners sold 55,707 TriSalus Life Sciences shares in Q4 2022, an estimated $553K.
Polar Asset Management Partners first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 5 quarters.
Polar Asset Management Partners's TriSalus Life Sciences position peaked at $6.55M in Q2 2021.
9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Polar Asset Management Partners's 13F filing for Q4 2022, filed 14 Feb 2023.